Octagon Capital Advisors LP Edgewise Therapeutics, Inc. Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$14.41 - $22.41 $720,500 - $1.12 Million
-50,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$14.11 - $24.1 $1.06 Million - $1.81 Million
-75,000 Reduced 60.0%
50,000 $830,000
Q1 2021

May 17, 2021
BUY
$30.0 - $35.99 $3.75 Million - $4.5 Million
125,000 New
125,000 $4.06 Million

Others Institutions Holding EWTX

# of Institutions
191
Shares Held
100M
Call Options Held
2.17M
Put Options Held
410K
View Full List

About Edgewise Therapeutics, Inc.

EWTX Quotes by TradingView
  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $2.02B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email